One of the main limitations of our meta-analysis is the small number of studies included, as there are currently only a few clinical trials using [99mTc]Tc-PSMA SPECT/CT for the diagnosis of prostate cancer and our meta-analysis results were based only on patient studies. The gene discussed is FOLH1; the disease is prostate carcinoma.